Hepatitis B - Articles and news items

Gilead’s Phase II study showed 99% HCV cure rates

Industry news / 26 April 2017 / Niamh Marriott, Junior Editor

Gilead Sciences’ Phase II studies demonstrated HCV cure rates of 99% in children, and 100% in patients co-infected with HCV and hepatitis B virus…

FDA approves Roche’s blood screening assay for donor screening

Industry news / 24 October 2016 / Niamh Louise Marriott, Digital Content Producer

The cobas MPX assay enables donor screening laboratories to apply the most advanced PCR-based diagnostic technology to the surveillance of donated blood…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+